SPDR Advertisement SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Galena Biopharma (GALE)

I sold my last shares of Gale this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
noretreat Member Profile
 
Followed By 109
Posts 7,525
Boards Moderated 3
Alias Born 01/06/10
160x600 placeholder
Galena Biopharma to Report Fourth Quarter and Year End 2014 Financial Results on Thursday, March 5, 2015 "GlobeNewswire Inc." - 2/19/2015 7:05:00 AM
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 2/13/2015 4:35:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2015 8:50:26 AM
Galena Biopharma Enrolls 700th Patient in NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial "GlobeNewswire Inc." - 2/9/2015 7:05:00 AM
Galena Biopharma Announces Orexo's Filing of a Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) S... "GlobeNewswire Inc." - 2/5/2015 7:05:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/30/2015 11:22:17 AM
Galena Biopharma to Present at the 17th Annual BIO CEO & Investor Conference "GlobeNewswire Inc." - 1/28/2015 7:05:00 AM
Galena Biopharma Hires Joseph Lasaga as Vice President, Business Development and Alliance Management "GlobeNewswire Inc." - 1/20/2015 7:05:00 AM
Galena Biopharma to Present at the Noble Financial Capital Markets 11th Annual Investor Conference "GlobeNewswire Inc." - 1/15/2015 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/14/2015 4:54:11 PM
Galena Biopharma Provides 2015 Outlook "GlobeNewswire Inc." - 1/8/2015 7:05:00 AM
Galena Biopharma Presents HER2 Screening Data Including Preliminary Leica Bond Oracle(TM) Results From the Phase 3 NeuVax(TM)... "GlobeNewswire Inc." - 12/11/2014 8:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/1/2014 4:54:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 11/21/2014 6:03:25 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 11/21/2014 6:02:01 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 11/20/2014 4:24:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/20/2014 4:21:42 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/3/2014 4:33:31 PM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 10/31/2014 4:50:52 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 10/22/2014 2:05:41 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 10/10/2014 9:44:34 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/26/2014 5:18:37 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 9/19/2014 2:26:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/18/2014 4:45:46 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/18/2014 4:36:37 PM
noretreat   Friday, 02/14/14 10:25:43 AM
Re: None
Post # of 6272 
I sold my last shares of Gale this morning, after lightening up by 90% over the previous month. It looks like these issues aren't going to go away quickly, and management does not seem to want to address them. Riding the run-up was nice.

Does not look like the CLDX of 2014 anymore, but who knows? There should be a bounce here a some point.

Men fear thought as they fear nothing else on earth -- more than ruin, more even than death. Thought is subversive and revolutionary, destructive and terrible, thought is merciless to privilege, established institutions, and comfortable habits.(Russell)
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist